Literature DB >> 3284642

Novel method for selective killing of transformed rodent cells through intercellular communication, with possible therapeutic applications.

H Yamasaki1, F Katoh.   

Abstract

A novel method for killing transformed cells selectively, without affecting surrounding nontransformed cells, has been developed. The method is based on our finding that transformed cells form their own gap-junctional communication compartment which is independent of that of adjacent nontransformed cells; transformed cells and adjacent normal cells transfer molecules through gap junctions among their homologous cells, but there is no heterologous transfer. Thus, when Lucifer Yellow CH is microinjected into transformed cells, it spreads only among the transformed cells and not to surrounding nontransformed cells. Subsequent irradiation of cells with blue light (around 430 nm) kills only those cells containing Lucifer Yellow CH (i.e., transformed cells), and surrounding normal cells continue to grow after treatment. We succeeded in killing BALB/c 3T3 transformed foci induced in situ by a chemical carcinogen or by an activated oncogene, and in killing tumorigenic rat liver epithelial cells cocultured with nontumorigenic counterparts. Potential development of this phenomenon for cancer therapy is suggested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284642

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Human adult stem cells as the target cells for the initiation of carcinogenesis and for the generation of "cancer stem cells".

Authors:  James E Trosko
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

2.  Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.

Authors:  M Mesnil; C Piccoli; G Tiraby; K Willecke; H Yamasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

Review 3.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

Review 4.  Field carcinogenesis and biological significance of the potential of the bystander effect: carcinogenesis, therapeutic response, and tissue regeneration.

Authors:  Hiroyuki Kuwano; Takehiko Yokobori; Tatsuya Miyazaki; Makoto Sohda; Tomonori Yoshida; Yoko Azuma; Hironori Tatsuki; Yasunari Ubukata; Nobuhiro Nakazawa; Kengo Kuriyama; Akihiko Sano; Makoto Sakai; Hiroomi Ogawa; Hiroshi Saeki; Ken Shirabe
Journal:  Surg Today       Date:  2022-05-16       Impact factor: 2.549

5.  5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.

Authors:  H Hagiwara; H Sato; Y Ohde; Y Takano; T Seki; T Ariga; N Hokaiwado; M Asamoto; T Shirai; Y Nagashima; T Yano
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

6.  The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment.

Authors:  Dominique Thuringer; Eric Solary; Carmen Garrido
Journal:  Front Mol Neurosci       Date:  2017-08-04       Impact factor: 5.639

Review 7.  Connexin and pannexin channels in cancer.

Authors:  Jean X Jiang; Silvia Penuela
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

Review 8.  Connexins and Pannexins: Important Players in Tumorigenesis, Metastasis and Potential Therapeutics.

Authors:  Sheila V Graham; Jean X Jiang; Marc Mesnil
Journal:  Int J Mol Sci       Date:  2018-06-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.